Search by Drug Name or NDC

    NDC 72850-0004-01 Stozyme 5.21; 5.21; 10.42; 36.46 1/1001; 1/1001; 1/1001; 1/1001 Details

    Stozyme 5.21; 5.21; 10.42; 36.46 1/1001; 1/1001; 1/1001; 1/1001

    Stozyme is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Chunwoo Pharmaceutical Co., Ltd.. The primary component is BOS TAURUS BILE; DIMETHICONE; HEMICELLULASE (ASPERGILLUS NIGER); PANCRELIPASE.

    Product Information

    NDC 72850-0004
    Product ID 72850-0004_96932453-80c3-4a44-e053-2a95a90a7bb6
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Stozyme
    Proprietary Name Suffix n/a
    Non-Proprietary Name pancreatin, hemicellulase, OX bile extract, dimethicone
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 5.21; 5.21; 10.42; 36.46
    Active Ingredient Units 1/1001; 1/1001; 1/1001; 1/1001
    Substance Name BOS TAURUS BILE; DIMETHICONE; HEMICELLULASE (ASPERGILLUS NIGER); PANCRELIPASE
    Labeler Name Chunwoo Pharmaceutical Co., Ltd.
    Pharmaceutical Class Skin Barrier Activity [PE]
    DEA Schedule n/a
    Marketing Category UNAPPROVED DRUG OTHER
    Application Number n/a
    Listing Certified Through 2022-12-31

    Package

    NDC 72850-0004-01 (72850000401)

    NDC Package Code 72850-0004-1
    Billing NDC 72850000401
    Package 10 TABLET in 1 BLISTER PACK (72850-0004-1)
    Marketing Start Date 2019-10-19
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 96932453-80c2-4a44-e053-2a95a90a7bb6 Details

    Revised: 11/2019